Angiotensin-Receptor Blockers (ARBs) and risk of Alzheimer ´s Disease: A meta-analysis.
CONCLUSION: ARB use may reduce the risk of incident AD. This association does not imply causation and further research is required to clarify potential mechanisms.
PMID: 32003701 [PubMed - as supplied by publisher]
Source: Current Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Oscanoa TJ, Amado J, Vidal X, Romero-Ortuno R Tags: Curr Clin Pharmacol Source Type: research